Jane Street
UBIO

Jane Street’s Proshares UltraPro NASDAQ Biotechnology UBIO Stock Holding History

Jane Street’s Portfolio UBIO Stock Details UBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-15,000
Closed -$300K – 5970
2018
Q4 		$300K Buy
+15,000
New +$424K ﹤0.01% 4068
2018
Q3 		– Sell
-9,500
Closed -$315K – 6004
2018
Q2 		$315K Buy
9,500
+2,000
+27% +$62.3K ﹤0.01% 4069
2018
Q1 		$239K Sell
7,500
-1,900
-20% -$69.8K ﹤0.01% 4273
2017
Q4 		$316K Sell
9,400
-9,400
-50% -$321K ﹤0.01% 3706
2017
Q3 		$727K Sell
18,800
-8,400
-31% -$292K ﹤0.01% 2650
2017
Q2 		$866K Buy
27,200
+19,100
+236% +$536K ﹤0.01% 2369
2017
Q1 		$224K Sell
8,100
-27,200
-77% -$717K ﹤0.01% 3749
2016
Q4 		$745K Sell
35,300
-28,200
-44% -$667K ﹤0.01% 2417
2016
Q3 		$1.84M Buy
63,500
+24,400
+62% +$695K 0.01% 1284
2016
Q2 		$829K Buy
39,100
+23,020
+143% +$583K ﹤0.01% 2194
2016
Q1 		$381K Buy
16,080
+3,040
+23% +$83.8K ﹤0.01% 2917
2015
Q4 		$755K Buy
+13,040
New +$690K ﹤0.01% 2041

Other funds holding UBIO

Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Jane Street's UBIO Position: Q1 2020 in Review

Jane Street sold out of Proshares UltraPro NASDAQ Biotechnology (UBIO) in Q1 2020, closing a stake of 56,492 shares — an estimated $1.85M sold.

Jane Street first reported a position in UBIO in Q4 2015 and held it in 12 quarters. The position peaked at $1.85M in Q4 2019. 1 fund tracked by Wall St. Rank holds UBIO as of Q1 2020.

  • Jane Street reported no remaining Proshares UltraPro NASDAQ Biotechnology position as of Q1 2020 after selling out during the quarter.
  • Jane Street sold 56,492 Proshares UltraPro NASDAQ Biotechnology shares in Q1 2020, an estimated $1.85M.
  • Jane Street first reported a position in Proshares UltraPro NASDAQ Biotechnology in Q4 2015 and held it in 12 quarters.
  • Jane Street's Proshares UltraPro NASDAQ Biotechnology position peaked at $1.85M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Proshares UltraPro NASDAQ Biotechnology as of Q1 2020.

Based on Jane Street's 13F filing for Q1 2020, filed 15 May 2020.